Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis

NCT06095596 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

334

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis (UC)

Interventions

DRUG: Upadacitinib
DRUG: Vedolizumab

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University